BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramia JM. Hilar cholangiocarcinoma. World J Gastrointest Oncol 2013; 5(7): 113-114 [PMID: 23919104 DOI: 10.4251/wjgo.v5.i7.113] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Lehrke HD, Heimbach JK, Wu TT, Jenkins SM, Gores GJ, Rosen CB, Mounajjed T. Prognostic Significance of the Histologic Response of Perihilar Cholangiocarcinoma to Preoperative Neoadjuvant Chemoradiation in Liver Explants. Am J Surg Pathol. 2016;40:510-518. [PMID: 26752544 DOI: 10.1097/pas.0000000000000588] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 4.2] [Reference Citation Analysis]
2 Zhang W, Yang ZQ, Shi HB, Liu S, Zhou WZ, Zhao LB. Placement of 125I seed strands and stents for a type IV Klatskin tumor. World J Gastroenterol 2015; 21(1): 373-376 [PMID: 25574114 DOI: 10.3748/wjg.v21.i1.373] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kammerer S, Meister T, Wolters H, Lessing M, Hüsing A, Domagk D, Floer M, Wilms C, Schmidt H, Senninger N, Köhler G, Heinzow HS. Preoperative prediction of curative surgery of perihilar cholangiocarcinoma by combination of endoscopic ultrasound and computed tomography. United European Gastroenterol J 2018;6:263-71. [PMID: 29511556 DOI: 10.1177/2050640617713651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Sun DX, Tan XD, Gao F, Xu J, Cui DX, Dai XW. Use of an autologous liver round ligament flap zeros postoperative bile leak after curative resection of hilar cholangiocarcinoma. PLoS One 2015;10:e0125977. [PMID: 25938440 DOI: 10.1371/journal.pone.0125977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Birgin E, Rasbach E, Reissfelder C, Rahbari NN. A systematic review and meta-analysis of caudate lobectomy for treatment of hilar cholangiocarcinoma. Eur J Surg Oncol 2020;46:747-53. [PMID: 31987703 DOI: 10.1016/j.ejso.2020.01.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3:18-34. [PMID: 24696835 DOI: 10.3978/j.issn.2304-3881.2014.02.05] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
7 Huang GL, Zhang W, Ren HY, Shen XY, Chen QX, Shen DY. Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways. Cancer Sci 2015;106:1515-23. [PMID: 26310932 DOI: 10.1111/cas.12802] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
8 Krampitz GW, Aloia TA. Staging of Biliary and Primary Liver Tumors. Surgical Oncology Clinics of North America 2019;28:663-83. [DOI: 10.1016/j.soc.2019.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Chen Y, Cha Z, Fang W, Qian B, Yu W, Li W, Yu G, Gao Y. The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma. Oncotarget 2015;6:20419-33. [PMID: 25971332 DOI: 10.18632/oncotarget.3983] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
10 Czhao AV, Shevchenko TV, Zharikov YO. [View on the problem of Klatskin tumor]. Khirurgiia (Mosk) 2015;:62-7. [PMID: 26103646 DOI: 10.17116/hirurgia2015462-67] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Tsuchikawa T, Hirano S, Okamura K, Matsumoto J, Tamoto E, Murakami S, Nakamura T, Ebihara Y, Kurashima Y, Shichinohe T. Advances in the surgical treatment of hilar cholangiocarcinoma. Expert Review of Gastroenterology & Hepatology 2014;9:369-74. [DOI: 10.1586/17474124.2015.960393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
12 Madhusudhan KS, Gamanagatti S, Gupta AK. Imaging and interventions in hilar cholangiocarcinoma: A review. World J Radiol 2015; 7(2): 28-44 [PMID: 25729485 DOI: 10.4329/wjr.v7.i2.28] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
13 Weiss MJ, Cosgrove D, Herman JM, Rastegar N, Kamel I, Pawlik TM. Multimodal treatment strategies for advanced hilar cholangiocarcinoma. Langenbecks Arch Surg. 2014;399:679-692. [PMID: 24962146 DOI: 10.1007/s00423-014-1219-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
14 Daradkeh S. A case series of hilar cholangiocarcinoma: A single surgeon experience over 20-years. Ann Med Surg (Lond) 2021;62:239-43. [PMID: 33537137 DOI: 10.1016/j.amsu.2021.01.059] [Reference Citation Analysis]
15 Xu D, Yi W, Chen Y, Ma L, Wang J, Yu G. Overexpression of Sig1R is closely associated with tumor progression and poor outcome in patients with hilar cholangiocarcinoma. Med Oncol 2014;31:261. [PMID: 25344871 DOI: 10.1007/s12032-014-0261-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]